Elevated serum type IV collagen: a sensitive indicator of the presence of cirrhosis in haemochromatosis.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of Hepatology

• Publication date

  1999-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0168-8278(99)80162-7PMID 10424282
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evidence for altered hepatic matrix degradation in genetic haemochromatosis

  1998cited by this paper
• A simple genetic test identifies 90% of UK patients with haemochromatosis

  1997cited by this paper
• Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosis.

  1997cited by this paper
• Tissue inhibitor of metalloproteinase-1 in the liver of patients with chronic liver disease.

  1997cited by this paper
• Cerebral benzodiazepine receptor binding in vivo in patients with recurrent hepatic encephalopathy

  1997cited by this paper
• the screening, diagnosis and optimal management of haemochromatosis

  1997cited by this paper
• Noninvasive diagnosis of hepatic fibrosis or cirrhosis.

  1997cited by this paper
• Circulating matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as serum markers of fibrosis in patients with chronic hepatitis C. Relationship to interferon response.

  1997cited by this paper
• Mutation analysis of the HLA-H gene in Italian hemochromatosis patients.

  1997cited by this paper
• A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosis

  1996cited by this paper
• Haemochromatosis and HLA–H

  1996cited by this paper
• Comparison of serum 7S fragment of type IV collagen and serum central triple-helix of type IV collagen for assessment of liver fibrosis in patients with chronic viral liver disease.

  1996cited by this paper
• Haemochromatosis and HLA–H

  1996cited by this paper
• Serum type IV collagen in various liver diseases in comparison with serum 7S collagen, laminin, and type III procollagen peptide

  1996cited by this paper
• Significance of serum tissue inhibitor of metalloproteinases-1 in various liver diseases.

  1996cited by this paper
• Long-term survival in patients with hereditary hemochromatosis.

  1996cited by this paper
• Serum procollagen III peptide concentration in iron overload

  1996cited by this paper
• Serum markers for connective tissue turnover in patients with chronic hepatitis B and chronic hepatitis C: a comparative analysis.

  1995cited by this paper
• Serum hyaluronate predicts response to interferon-alpha therapy in patients with chronic hepatitis C.

  1995cited by this paper
• Tissue inhibitor of metalloproteinase is increased in the serum of precirrhotic and cirrhotic alcoholic patients and can serve as a marker of fibrosis

  1994cited by this paper
• Serum type III procollagen peptide, type IV collagen 7S domain, central triple‐helix of type IV collagen and tissue inhibitor of metalloproteinases in patients with chronic viral liver disease: Relationship to liver histology

  1994cited by this paper
• A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 2 (72-kDa gelatinase/type IV collagenase) using monoclonal antibodies.

  1993cited by this paper
• Significance of serum type-IV collagen levels in various liver diseases. Measurement with a one-step sandwich enzyme immunoassay using monoclonal antibodies with specificity for pepsin-solubilized type-IV collagen.

  1992cited by this paper
• Human hepatic lipocytes synthesize tissue inhibitor of metalloproteinases-1. Implications for regulation of matrix degradation in liver.

  1992cited by this paper
• Serum procollagen peptides and collagen type VI for the assessment of activity and degree of hepatic fibrosis in schistosomiasis and alcoholic liver disease

  1992cited by this paper
• Biochemical markers of hepatic fibrosis.

  1991cited by this paper
• Classification of chronic viral hepatitis: a need for reassessment.

  1991cited by this paper
• One-step sandwich enzyme immunoassay for human laminin using monoclonal antibodies.

  1990cited by this paper
• Rapid one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases. An application for rheumatoid arthritis serum and plasma.

  1990cited by this paper
• Serum concentrations of the carboxyterminal cross-linking domain of procollagen type IV (NC1) and the aminoterminal propeptide of procollagen type III (PIIIP) in chronic liver disease.

  1990cited by this paper
• One step sandwich enzyme immunoassay for human type IV collagen using monoclonal antibodies.

  1989cited by this paper
• Use of polyethylene glycol in radioimmunoassays involving tritium labels.

  1988cited by this paper
• Hepatocellular carcinoma in primary haemochromatosis in the absence of cirrhosis.

  1988cited by this paper
• Serum procollagen‐III‐peptide: Failure to reflect the extent of hepatic fibrosis

  1986cited by this paper
• Serum type III procollagen peptide in alcoholic liver disease and idiopathic hemochromatosis: Its relationship to hepatic fibrosis, activity of the disease and iron overload

  1985cited by this paper

• Correlation Between Real-Time Shear Wave Elastography and Liver Serum Markers in Determining the Stage of Liver Fibrosis in Patients with Chronic Liver Diseases

  2024cites this paper
• Research Progress of Fibroblasts in Human Diseases

  2024cites this paper
• Down-regulation of GLT25D1 inhibited collagen secretion and involved in liver fibrogenesis.

  2019cites this paper
• GPVI and CLEC-2 regulation and signal transduction: from development through to adulthood

  2019cites this paper
• Usefulness of Liver Stiffness on Ultrasound Shear-Wave Elastography for the Evaluation of Central Venous Pressure in Children With Heart Diseases.

  2019cites this paper
• Non-invasive Markers of Liver Fibrosis: Adjuncts or Alternatives to Liver Biopsy?

  2016cites this paper
• Preparation and partial characterization of monoclonal antibodies specific for the nascent non-triple helical form of the type IV collagen alpha 1 chain

  2016cites this paper
• Determination of collagen type IV by Surface Plasmon Resonance Imaging using a specific biosensor.

  2016cites this paper
• Using digital gene expression profile to detect representational difference of Chlamys farreri genes after laboratory exposure to persistent organic pollutants

  2016cites this paper
• Increased soluble GPVI levels in cirrhosis: evidence for early in vivo platelet activation

  2016cites this paper
• A career forged in iron

  2015cites this paper
• Searching for biomarkers of comorbidities in sera of treated HIV‐infected patients by isoelectric focusing

  2015cites this paper
• Probable case of drug reaction with eosinophilia and systemic symptom syndrome due to combination therapy with daclatasvir and asunaprevir.

  2015cites this paper
• IL28B genotyping and treatment of HCV infected subjects

  2014cites this paper
• Mechanism of SOX9 action as a route to diagnostic strategies in liver fibrosis

  2013cites this paper
• Genetic and Functional Characterization of the N-Terminal Region of the Hepatitis C Virus NS2 Protein

  2013cites this paper
• Markers in nonalcoholic steatohepatitis.

  2013cites this paper
• Molecular Mechanisms Underlying Occult Hepatitis B Virus Infection

  2012cites this paper
• Review article: the iron overload syndromes

  2012influential citation
• Bioimpedance Changes in Rats with CCl 4 -Induced Liver Fibrosis

  2011cites this paper
• A brief review on molecular, genetic and imaging techniques for HCV fibrosis evaluation

  2011cites this paper
• Non-invasive diagnosis of liver fibrosis

  2011cites this paper
• Pathology of Hepatic Iron Overload

  2011cites this paper
• Non-invasive methods for liver fibrosis prediction in hemochromatosis: One step beyond.

  2010cites this paper
• Circulating markers of liver fibrosis progression.

  2010cites this paper
• Toward surface quantification of liver fibrosis progression.

  2010cites this paper
• Paediatric cholestatic liver disease: Diagnosis, assessment of disease progression and mechanisms of fibrogenesis.

  2010cites this paper
• NON INVASIVE EVALUATION OF LIVER FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS B AND C

  2009cites this paper
• Interleukin-1 participates in the progression from liver injury to fibrosis.

  2009cites this paper
• Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosis

  2009cites this paper
• The global burden of iron overload

  2009cites this paper
• Hereditary hemochromatosis in the post‐HFE era

  2008cites this paper
• Diagnosis and quantitation of fibrosis.

  2008cites this paper
• [Predicting liver fibrosis with non-invasive tests--a hope for the future].

  2008cites this paper
• Effects of Hepatitis B Surface and Hepatitis B Core Antigens from Hepatitis B Virus Genotypes B and C on In Vitro Apoptosis

  2007cites this paper
• Efficacy of Serum Hyaluronic Acid Level for Predicting Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease

  2006cites this paper
• Hepatotoxicity of iron overload: mechanisms of iron-induced hepatic fibrogenesis.

  2005cites this paper
• Hepatotoxicity of Iron Overload: Mechanisms of Iron-Induced Hepatic Fibrogenesis

  2005influential citation
• Role of early case detection by screening relatives of patients with HFE-associated hereditary haemochromatosis.

  2005cites this paper
• Noninvasive assessment of liver fibrosis.

  2005cites this paper
• Biomarkers of Cancer Risk and Therapeutic Benefit: New Technologies, New Opportunities, and Some Challenges

  2004cites this paper
• Evaluation of Liver Fibrosis: A Concise Review

  2004cites this paper
• Hereditary haemochromatosis.

  2004cites this paper
• Serum markers of hepatic fibrogenesis in cystic fibrosis liver disease.

  2004cites this paper
• Grading and staging of hepatic fibrosis, and its relationship with noninvasive diagnostic parameters.

  2003cites this paper
• Inhibition on the production of collagen type I, III of activated hepatic stellate cells by antisense TIMP-1 recombinant plasmid.

  2003cites this paper
• Current directions in hemochromatosis research: towards an understanding of the role of iron overload and the HFE gene mutations in the development of clinical disease.

  2003cites this paper
• Expression of TIMP-1 in normal and fibrotic livers in rats

  2003cites this paper
• Penetrance of HFE‐related hemochromatosis in perspectiveW

  2002cites this paper
• Tumor necrosis factor α promoter polymorphisms and liver abnormalities of homozygotes for the 845G>A (C282Y) hereditary hemochromatosis mutation

  2002cites this paper
• Diagnosis and management of genetic haemochromatosis.

  2002cites this paper
• Glycosylation of V region genes in follicular lymphoma as a result of the somatic hypermutation mechanism

  2002cites this paper
• Hereditary hemochromatosis and iron overload diseases

  2002cites this paper
• Tumor necrosis factor alpha promoter polymorphisms and liver abnormalities of homozygotes for the 845G>A(C282Y) hereditary hemochromatosis mutation.

  2002cites this paper
• Methodologic research on TIMP-1, TIMP-2 detection as a new diagnostic index for hepatic fibrosis and its significance.

  2002cites this paper
• Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USA

  2002cites this paper
• mutationof homozygotes for the 845G>A (C282Y) hereditary hemochromatosis promoter polymorphisms and liver abnormalities a Tumor necrosis factor

  2002cites this paper
• Glycosylation of V region genes in follicular lymphoma as a result of the somatic hypermutation mechanism.

  2002cites this paper
• Haemochromatosis

  2002cites this paper
• HFE and Non-HFE Hemochromatosis

  2002cites this paper
• Characterization of serum activin-A and follistatin and their relation to virological and histological determinants in chronic viral hepatitis.

  2001cites this paper
• Detection of alcoholic liver disease.

  2001cites this paper
• [Hereditary hemochromatosis. Case report and review of the literature].

  2001cites this paper
• What’s new in hemochromatosis

  2001cites this paper
• Hemocromatose hereditária: relato de caso e revisão da literatura

  2001cites this paper
• Inhibiting effect of antisense oligonucleotides phosphorthioate on gene expression of TIMP-1 in rat liver fibrosis.

  2001cites this paper
• Diagnostic value of serum type IV collagen test in comparison with platelet count for predicting the fibrotic stage in patients with chronic hepatitis C

  2001cites this paper
• Role of myofibroblasts in tumour encapsulation of hepatocellular carcinoma in haemochromatosis.

  2001cites this paper
• Transplantation in the patient with hepatitis C.

  2000cites this paper
• Perioperative management of a common disorder: hereditary haemochromatosis

  2000cites this paper